Sarepta Therapeutics (SRPT) Said to Price $300M at $59.75 - Feurstein

September 22, 2016 5:38 PM EDT Send to a Friend
Sarepta Therapeutics (NASDAQ: SRPT) offering 4-5x oversubscribed ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login